Form 4 for COCO Vita Coco Company, Inc.
Accepted 2022-08-16 00:00:00 ET · period of report 2022-08-12 · accession 0001886259-22-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-08-16 | 2022-08-12+ | COCO | Benmoussa Kevin | Gbl CFO | M - OptEx | $10.18 | +86.9K | 40.1K | New | +$884.4K |
| DM | 2022-08-16 | 2022-08-12+ | COCO | Benmoussa Kevin | Gbl CFO | S - Sale+OE | $13.37 | -86.9K | 14.1K | -86% | -$1.16M |
| DM | 2022-08-16 | 2022-08-12+ | COCO | Benmoussa Kevin | Gbl CFO | M - OptEx | $0.00 | -86.9K | 83.8K | -51% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-12 | M | A | 56,875 | $10.18 | 67,025 | D | — | — | |
| 2 | Common | Common Stock | 2022-08-12 | S | D | 56,875 | $12.76 | 10,150 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $12.50 to $13.02, inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2022-08-15 | S | D | 3,977 | $13.78 | 10,150 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.99, inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. (F5) Includes (i) 10,000 unvested RSUs that vest in four annual installments starting November 27, 2022 provided that the Reporting Person remains in continuous service on each vesting date and (ii) 150 shares of common stock purchased directly from the issuer's underwriters in a Reserved Share Program. |
| 4 | Common | Common Stock | 2022-08-15 | S | D | 10,000 | $15.01 | 30,150 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.03, inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
| 5 | Common | Common Stock | 2022-08-15 | S | D | 16,023 | $14.43 | 14,127 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.69, inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 6 | Common | Common Stock | 2022-08-15 | M | A | 30,000 | $10.18 | 40,150 | D | — | — | |
| 7 | Derivative | Stock Option (Right to Buy) | 2022-08-12 | M | D | 56,875 | $0.00 | 56,875 | D | $10.18 · — to 2030-02-10 | 56,875 Common Stock | (F6) The stock option is fully vested and currently exercisable as to 56,875 underlying shares, with the remaining vesting on February 10, 2024. |
| 8 | Derivative | Stock Option (Right to Buy) | 2022-08-15 | M | D | 30,000 | $0.00 | 83,750 | D | $10.18 · — to 2029-12-16 | 30,000 Common Stock | (F7) The stock option is fully vested and currently exercisable. |